SNDX-5613 (Revumenib) MCE (HY-136175)? Try a better option.

A Depth-Data-Driven Comparison: Critical Reasons Leading Labs are Switching from MCE to Selleck’s SNDX-5613 (Revumenib).

SNDX-5613 (Revumenib) Selleck VS MCE

SNDX-5613 (Revumenib)	Selleck(S8996)	MCE(HY-136175)
Free Aliquoting Service		N/A
Price	5mg, USD 197.0	10mg, USD 350.0
Purity	99.93%	99.99%
Citations	6	16
Technical Support	95.37% response rate within 2 hours	Unknown
Knowledge	SNDX-5613 (Revumenib) Mechanism of Action: Menin Inhibition in Leukemic Cell Research SNDX-5613 (Revumenib) Working Concentration \| Cell Culture \| Treatment SNDX-5613 (Revumenib) Solubility in DMSO SNDX-5613 (Revumenib) Storage & Stability SNDX-5613 (Revumenib) Combination Database SNDX-5613 (Revumenib) Molecular Weight \| Chemical Structure \| Stock Solution SNDX-5613 (Revumenib) SDS｜MSDS	Unknown

MCE is sourced from their official website（1/20/2026）